deltatrials
Completed PHASE2 NCT00002608

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Cisplatin, Doxorubicin and Tamoxifen in the Treatment of Incurable Soft Tissue and Endocrine Malignancies

Sponsor: Ottawa Regional Cancer Centre

Conditions Adrenocortical Carcinoma Brain and Central Nervous System Tumors Head and Neck Cancer Liver Cancer Malignant Mesothelioma Pheochromocytoma Sarcoma
Interventions cisplatin conventional surgery doxorubicin hydrochloride radiation therapy tamoxifen citrate
Updated 5 times since 2017 Last updated: Jul 9, 2013 Started: May 31, 1994 Completion: Apr 30, 2005

A PHASE2 clinical study on Adrenocortical Carcinoma and Brain and Central Nervous System Tumors, this trial is completed. The trial is conducted by Ottawa Regional Cancer Centre and has accumulated 5 data snapshots since 1994. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

May 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ottawa Regional Cancer Centre
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Ottawa, Canada